| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/28/2005 | WO2005038430A2 Viral fibers |
| 04/28/2005 | WO2005038035A2 Methods for producing and using in vivo pseudotyped retroviruses |
| 04/28/2005 | WO2005038023A1 Method of expressing activated membrane protease protein complex using budding baculovirus |
| 04/28/2005 | WO2005037856A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | WO2005024039A3 Improved method for generating influenza viruses and vaccines |
| 04/28/2005 | WO2005014626A3 Recombinant human metapneumovirus and its use |
| 04/28/2005 | WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto |
| 04/28/2005 | WO2004032622A3 Production of peptides in plants as viral coat protein fusions |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | US20050090435 nucleotide sequences, genetic vectors comprising and/or genes expressing the nucleotide sequences, use to transform plant cells to produce proteins or fragments of proteins used as anticarcinogenic agents |
| 04/28/2005 | US20050090010 New family of vectors capable of cloning nucleic acids of wide range size and preferably very long ones, with high efficiency of excision and reduced background and contamination; also provided are methods of cloning and for preparing bulk library using such vectors |
| 04/28/2005 | US20050089999 Method for the production and purification of adenoviral vectors |
| 04/28/2005 | US20050089985 Rescue of canine distemper virus from cdna |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089532 Method of protein production using mitochondrial translation system |
| 04/28/2005 | US20050089531 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome |
| 04/28/2005 | US20050089525 Subunit respiratory syncytial virus vaccine preparation |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | CA2542674A1 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | CA2542427A1 Viral fibers |
| 04/27/2005 | EP1526175A2 Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics |
| 04/27/2005 | EP1526174A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526173A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526172A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | CN1610748A Recombinant MVA capable of expressing structural HCV antigens |
| 04/27/2005 | CN1609204A Bivalent hepatitis B-encephalitis B vaccine |
| 04/27/2005 | CN1609201A Gene engineering cell line of high expression recombinant protein and high-yield baculovirus |
| 04/27/2005 | CN1198934C RNA virus vector having contact infiltration capability |
| 04/26/2005 | US6884786 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/26/2005 | US6884623 Using plant virions for vaccine preparation; gene therapy |
| 04/26/2005 | US6884613 Purification of preferential viral particles; obtain solution containing viral particles, mix with polyelectrolyte, centrifuge, recover pellet, separate viral particles from pellet |
| 04/21/2005 | WO2005035745A1 Method of inactivating virus and virus inactivating apparatus |
| 04/21/2005 | WO2005035744A1 Tumor targeting two genes-virus, the methods to construct it and the use thereof |
| 04/21/2005 | WO2005035743A1 Method for large-scale production, isolation, purification and the uses of multi-type recombinant adeno-associated virus vectors |
| 04/21/2005 | WO2005035712A2 Methods and compositions for infectious cdna of sars coronavirus |
| 04/21/2005 | WO2005035556A2 Sars-coronavirus virus-like particles and methods of use |
| 04/21/2005 | WO2004108940A3 Viral genome vectors |
| 04/21/2005 | WO2004074507A3 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 04/21/2005 | WO2004041156A3 Method for determining sensitivity to a bacteriophage |
| 04/21/2005 | WO2004009802A3 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/21/2005 | WO2004009768A3 Viral vectors containing recombination sites |
| 04/21/2005 | US20050084947 Recombinant RSV virus expression systems and vaccines |
| 04/21/2005 | US20050084503 Continuous cell line for the production of vaccines |
| 04/21/2005 | US20050084502 Equine herpesvirus vaccine |
| 04/21/2005 | US20050084480 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 04/20/2005 | EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 04/20/2005 | EP1523563A2 Modified adenoviral fiber with ablated to cellular receptors |
| 04/20/2005 | EP1002120B1 Chimeric adenoviral vectors |
| 04/20/2005 | EP0787200B1 Improved adenovirus and methods of use thereof |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | CN1607248A Multifunctional anticancer recombinant adenovirus |
| 04/20/2005 | CN1197961C BHV-1 gene-deleted virus vaccine |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2139507C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 04/14/2005 | WO2005032487A2 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 04/14/2005 | WO2005032457A2 Vectors and methods for immunization against norwalk virus using transgenic plants |
| 04/14/2005 | WO2005009372A3 Marek’s disease virus vaccine |
| 04/14/2005 | WO2005003315A3 Compositions and methods for peptide-assisted transfection |
| 04/14/2005 | WO2005002512A3 Immunotherapeutic vaccine strategy |
| 04/14/2005 | US20050080027 Methods enabling the production yield of viral vectors derived from piroviruses to be improved by using DNA methylation inhibitors and/or Herpes viruses in the production of viral vectors derived from parvoviruses; suitable for transferring genes into mammalian cells, in particular into human cells |
| 04/14/2005 | US20050079488 For use in expression constructs for expressing gene products, and methods of using it |
| 04/14/2005 | CA2814613A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1180153B1 Phage-dependent super-production of biologically active proteins and peptides |
| 04/13/2005 | EP1074624B1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | CN1606616A Method for the recovery and purification of poxviruses from infected cells using high pressure homogenisation |
| 04/13/2005 | CN1606456A Restricted expression lentiviral vectors |
| 04/13/2005 | CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS) |
| 04/13/2005 | CN1196780C Novel methods for rescue of RNA viruses |
| 04/12/2005 | US6878860 Comprises antisense nucleotides sequences transformed and expressed in tomato for controlling flowering; gene expression inhibition and tissue engineering |
| 04/12/2005 | US6878549 Generating expression vector for use as gene transfer tool |
| 04/12/2005 | US6878541 Papilloma pseudo-virus and preparation |
| 04/12/2005 | US6878372 Methods of preventing and treating flavivirus infection in animals |
| 04/07/2005 | WO2005030943A1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof |
| 04/07/2005 | WO2005030139A2 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | WO2005012535A3 Method for producing life attenuated viruses and use of viral particles thus produced. |
| 04/07/2005 | WO2005005625A3 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 04/07/2005 | WO2004096842A3 Sars virus nucleotide and amino acid sequences and uses thereof |
| 04/07/2005 | WO2004066947A3 Hyperthermia oncolysis co-therapy |
| 04/07/2005 | US20050074889 Transcription reporter vector for use as tool in modifying phenotypic expression of cells; tissue engineering; high throughput assay |
| 04/07/2005 | US20050074888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2005 | US20050074885 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/07/2005 | US20050074881 Chronic pathogen-expressing cell lines |
| 04/07/2005 | US20050074757 Compositions and methods for inhibiting expression of a mutant gene |
| 04/07/2005 | US20050074752 Expression vector comprising nucleotide sequences coding viral regulatory protein for use in transformation of muscle cell and generating vaccine for prevention of viral infection |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/06/2005 | EP1520008A1 Animal protein free media for cultivation of cells |
| 04/06/2005 | CN1604961A Avian embryo particulate biomass for the production of virus antigens |
| 04/06/2005 | CN1603418A Method for preparing infective hog cholera virus cDNA carrier and use thereof |
| 04/06/2005 | CN1603404A Oncolytic adenovirus with target for liver cancer and its preparation method and use |
| 04/06/2005 | CN1195864C Slowviral vector |
| 04/06/2005 | CN1195863C Retroviral vectors |
| 04/06/2005 | CN1195854C Porcine circovirus recombinant poxvirus vaccine |
| 04/05/2005 | US6875856 Recombinant infectious laryngotracheitis virus and uses thereof |
| 04/05/2005 | US6875600 Mixed cell diagnostic systems |